Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by BidingTime

V.LME

RE:RE:RE:Private placement

Indeed... More a curb than a wall 

October 23, 2024

V.LME

RE:1 day closer

Some decent volumes this week and price has ticked up and held at .43. And...

October 4, 2024

V.LME

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Top insider for junior miners

That's a very specific number to hope for...

September 27, 2024

V.LME

RE:Help me I’m dumb

With junior miners risk is the name of the game, but the disclosures relating...

August 31, 2024

V.LME

RE:Today’s Press Release

It's hard to find fault in the message in this PR - significant GEOs at...

August 23, 2024

V.LME

RE:August 21st

More of the same! Yesterday's news was the event for the month. While we...

August 21, 2024

V.LME

RE:RE:New Press Release - Laurion Announces Next Steps with a Leading Financial Advisor to Explore Strategic Opportunities

More USCG... More of the same 

August 20, 2024

V.LME

RE:RE:RE:RE:RE:RE:RE:Level 2 Data pre open - Aug 7, 2024 9:04am

Would love to jump on - but trading volumes of 7-9k a day (ya ya on the...

August 7, 2024

V.LME

RE:Price of Gold by year end

So much depends on political factors in the US, war zones abroad, central...

July 18, 2024

V.LME

RE:RE:RE:Very informative interview and an unexpected promotion

If this is the same guy... https://www.goerie.com/story/special/2020/02/04...

June 6, 2024

V.LME

RE:RE:RE:RE:RE:New Press Release - LAURION Announces 2024 Field Exploration Plans and Updates on Ishkoday Project

We could indeed interpret this release just as you say JoJo - and there have...

June 4, 2024

V.LME

RE:RE:RE:Read Mgmt Circulars for direction

What also adds credence to the significance of that meeting, beside it being...

May 29, 2024

V.LME

RE:RE:RE:Gogo wings - Two bucks

What hype are you seeing? It's entirely possible that the SH and Reddit...

May 21, 2024

V.LME

RE:RE:Consolation

Business as usual. A good investment is a good investment

May 16, 2024

V.LME

RE:RE:RE:RE:RE:USCG Update- Doug

Doug posted this back in Feb  https://stockhouse.com/companies...

May 9, 2024

V.LME

RE:RE:RE:RE:RE:RE:.20s

That would be shocking. Dumping at market just prior to close on Friday is...

April 29, 2024

V.LME

RE:Join LME on social media

I like the profile description on IG confirming 10+ million gold oz estimated...

April 9, 2024

V.LME

RE:Will this week be THE week?

It's spring time and hope abounds. It's as good a week as any to...

March 31, 2024

V.LME

RE:RE:RE:Acquisition of Argonaut Gold this morning!

Ouch

March 27, 2024

V.LME

RE:Acquisition of Argonaut Gold this morning!

Ice thawing on the M&A front is a good thing for others in the small cap...

March 27, 2024

1 2 3 4 Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »